An expert discusses how patients with vitiligo are often initially misdiagnosed by primary care providers as having fungal infections before being referred to dermatologists, with care coordination typically involving endocrinologists for thyroid management and psychologists for mental health support.
Video content above is prompted by the following:
Vitiligo diagnosis frequently involves multiple healthcare providers, with primary care physicians often initially misdiagnosing the condition as fungal infections before referring to dermatology specialists. This diagnostic delay occurs particularly in patients with lighter skin tones, where the contrast between normal and depigmented skin may be subtle and easily overlooked. Dermatologists rarely see vitiligo patients as initial presentations, with most cases arriving after unsuccessful primary care treatments, highlighting the need for improved diagnostic education across healthcare disciplines.
Effective vitiligo management typically requires coordination between dermatologists as primary treatment providers and other specialists when comorbid conditions develop. Endocrinologists or primary care providers manage concurrent thyroid disease, requiring ongoing communication and shared progress notes to ensure comprehensive patient care. This collaborative approach proves essential for addressing both the dermatologic manifestations and associated autoimmune conditions that frequently accompany vitiligo.
The psychological impact of vitiligo necessitates integration of mental health professionals into the care team, particularly for younger patients struggling with social adaptation and self-esteem issues. Patients commonly experience depression, loneliness and despair, especially when they haven’t encountered others with similar conditions. The visible nature of vitiligo, combined with the social pressure to “fit in” during adolescence, creates substantial psychological burden requiring professional counseling support. Dermatologists increasingly recognize that addressing the psychological aspects of vitiligo is equally important as providing medical treatment for optimal patient outcomes.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Patients Express Concerns Over Costs, Risks of Gene Therapies for Sickle Cell Disease
December 12th 2024Research at the annual meeting of the American Society of Hematology evaluated patient and caregiver perspectives on gene therapies for sickle cell disease, which offer great potential but have had slow uptake.
Read More
Evolving Role of Statins in Managing CV Risk in HIV | ID Week 2024
October 18th 2024Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle Cespedes, M.D., M.S., professor of medicine, Icahn School of Medicine at Mount Sinai and Mount Sinai Health System.
Read More